Results 111 to 120 of about 291,790 (306)

Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface. [PDF]

J Infect, 2021
Li KK, Woo YM, Stirrup O, Hughes J, Ho A, Filipe ADS, Johnson N, Smollett K, Mair D, Carmichael S, Tong L, Nichols J, Aranday-Cortes E, Brunker K, Parr YA, Nomikou K, McDonald SE, Niebel M, Asamaphan P, Sreenu VB, Robertson DL, Taggart A, Jesudason N, Shah R, Shepherd J, Singer J, Taylor AHM, Cousland Z, Price J, Lees JS, Jones TPW, Lopez CV, MacLean A, Starinskij I, Gunson R, Morris STW, Thomson PC, Geddes CC, Traynor JP, Breuer J, Thomson EC, Mark PB, COVID-19 Genomics UK (COG-UK) consortium.   +42 more
europepmc   +2 more sources

IgA Nephropathy: New Aspects in Pathophysiology and Pathogenesis [PDF]

European Medical Journal Nephrology, 2015
Knowledge of the pathophysiology of immunoglobulin A nephropathy (IgAN) has progressed significantly, with this disease being clearly identified as an autoimmune disease with a peculiar autoantigen (galactosedeficient IgA1 [Gd-IgA1]), specific ...
Francois Berthoux, Hesham Mohey, Nicolas Maillard, Christophe Mariat   +3 more
doaj  

Leadless Pacemaker Implantation in Renal Dialysis Patient With No Vascular Access. [PDF]

Korean Circ J, 2023
Afendoulis D, Voutas P, Papagiannis N, Moutafi M, Sitaras P, Maratsos A, Sideris S, Kartalis A.   +7 more
europepmc   +1 more source

The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia‐Associated Kidney Function

American Journal of Hematology, EarlyView.
ABSTRACT Progressive kidney injury is a major cause of morbidity and mortality in sickle cell anemia (SCA). The high risk APOL1 G1/G2 variants contribute to the development of kidney disease in individuals of African ancestry, including those with SCA.
Sara R. Rashkin, Guolian Kang, Clifford M. Takemoto, Mitchell J. Weiss, Kenneth I. Ataga, Santosh L. Saraf, Jeffrey Lebensburger, Rima S. Zahr   +7 more
wiley   +1 more source

Left ventricular hypertrophy among chronic kidney disease patients in Ghana

The Pan African Medical Journal, 2017
INTRODUCTION: The presence of left ventricular hypertrophy (LVH) in patients with Chronic Kidney Disease (CKD) is associated with worsening cardiovascular outcomes. There is a dearth of data on LVH in Ghanaian CKD patients.
Yaw Ampem Amoako, Dennis Odai Laryea, George Bedu-Addo, Bernard Cudjoe Nkum, Jacob Plange-Rhule   +4 more
doaj   +1 more source

Learned Helplessness in Renal Dialysis Patients: Concept Analysis with an Evolutionary Approach. [PDF]

Patient Prefer Adherence, 2022
Xie C, Li L, Li Y.
europepmc   +1 more source

The Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma With Renal Impairment: A Systematic Review

American Journal of Hematology, EarlyView.
ABSTRACT Renal impairment (RI), defined as estimated glomerular filtration rate less than 60 mL/min with or without the need for dialysis, is a frequent and severe complication in patients with relapsed/refractory multiple myeloma (RRMM), as it can affect patient prognosis, drug metabolism and treatment options.
Ioannis Ntanasis‐Stathopoulos, Sotirios Manganas, Charalampos Filippatos, Konstantinos Karamouzis, Maria Gavriatopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios‐Athanasios Dimopoulos   +7 more
wiley   +1 more source

POS-338 GASTRO-INTESTINAL ANGIODYSPLASIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Kidney International Reports, 2021
S. MEKKI, I. Mami, B. Ben Kaab, H. Ghabi, H. Jbali, L. Ben Fatma, L. Raies, M.K. Zouaghi   +7 more
doaj   +1 more source

Low-Protein Diet Supplemented with Keto Acids Is Associated with Suppression of Small-Solute Peritoneal Transport Rate in Peritoneal Dialysis Patients

International Journal of Nephrology, 2011
Objective. We investigate whether low-protein diet would show benefits in suppressing peritoneal transport rate in peritoneal dialysis (PD) patients. Methods.
Na Jiang, Jiaqi Qian, Aiwu Lin, Wei Fang, Weiming Zhang, Liou Cao, Qin Wang, Zhaohui Ni, Qiang Yao   +8 more
doaj   +1 more source

A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report. [PDF]

Int Immunopharmacol, 2023
Tuthill CW, Awad A, Parrigon M, Ershler WB.   +3 more
europepmc   +1 more source